Equities Analysts Issue Forecasts for Biogen FY2025 Earnings
Equities research analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for Biogen in a research note ...
Biogen (NASDAQ:BIIB) Given Hold Rating at Needham & Company LLC
Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at Needham & ...
pharmaphorum6d
Fourth Humira biosimilar set for EU approval
Biosimilar adalimumab is backed by robust science ... Amgen (Amgevita and Solymbi), Boehringer Ingelheim (Cyltezo), Samsung Bioepis (Imraldi) will be key, with health systems keen to benefit ...
Yahoo Finance3d
Biogen Inc. (BIIB)
After hours: 7:52:17 p.m. EST ...
BMJ4d
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial
Objective CONCERTO was a randomised, double-blind, parallel-armed study of methotrexate (MTX) in combination with adalimumab to assess whether an increasing trend of efficacy and decreased safety ...
Yahoo Finance5d
Biogen Inc. (BIIB)
Pre-market: 4:26:51 am GMT-5 ...
BMJ4d
Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner
2 Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands 3 Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, ...